Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections

Immunological Reviews

Volumn 159, Issue , 1997, Pages 105-117

  Doherty, Peter C ^a   Topham, David J ^a   Tripp, Ralph A ^a   Cardin, Rhonda D ^a   Brooks, James W ^a   Stevenson, Philip G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HERPES VIRUS; HUMAN; IMMUNOSURVEILLANCE; INFLUENZA VIRUS; LUNG ALVEOLUS EPITHELIUM; LYMPH NODE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SENDAI VIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LATENCY;

EID: 0030664401     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01010.x     Document Type: Review

References (101)

1. Kagi D, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994;369:31-37.
2. Ehtisham S, Sunil-Chandra NP, Nash AA. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 1993;67:5247-5252.
3. Nash AA, Sunil-Chandra NP. Interactions of the murine gammaherpesvirus with the immune system. Curr Opin Immunol 1994;6:560-563.
4. + T cells. J Exp Med 1996;184:863-871.
5. Sunil-Chandra NP, Efstathiou S, Nash AA. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol 1992;73:3275-3279.
6. Usherwood EJ, Stewart JP, Robertson K, Allen DJ, Nash AA. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol 1996;77:2819-2825.
7. Lightman S, Cobbold S, Waldmann H, Askonas BA. Do L3T4+ T cells act as effector cells in protection against influenza virus infection? Immunology 1987;62:139-144.
8. + T cells. J Exp Med 1991;174:875-880.
9. Bender BS, Croghan T, Zhang L, Small PA Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992;175:1143-1145.
10. + T cells. J Immunol 1992;149:1319-1325.
11. Doherty PC, Topham DJ, Tripp RA. Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev 1996;150:23-44.
12. + T cells. Virology 1995;210:179-185.
13. Tripp RA, Lahti JM, Doherty PC. Laser light suicide of proliferating virus-specific CD8+ T cells in an in vivo response. J Immunol 1995;155:3719-3721.
14. Brownstein DG, Smith AL, Johnson EA. Sendai virus infection in genetically resistant and susceptible mice. Am J Pathol 1981;105:156-163.
15. Eichelberger MC, Wang M, Allan W, Webster RG, Doherty PC. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol 1991;72:1695-1698.
16. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med 1989;170:1285-1301.
17. Hamilton-Easton A, Eichelberger M. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol 1995;69:6359-6366.
18. McWilliam AS, et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996;184:2429-2432.
19. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol 1993;150:5494-5500.
20. + T cells in respiratory virus infections. J Immunol 1995;154:6013-6021.
21. Hou S, Hyland L, Ryan KW, Portner A, Doherty PC. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 1994;369:652-654.
22. + T cell memory in the absence of B cells and Ig. J Immunol 1996;157:2947-2952.
23. Carding SR, Allan W, McMickle A, Doherty PC. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med 1993;177:475-482.
24. Sarawar SR, Doherty PC. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol 1994;68:3112-3119.
25. Mo XY, Sarawar SR, Doherty PC. Induction of cytokines in mice with parainfluenza pneumonia. J Virol 1995;69:1288-1291.
26. Baumgarth N, Kelso A. Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur J Immunol 1996;26:2189-2197.
27. Sarawar SR, et al. Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Reg Immunol 1993;5:142-150.
28. Mo XY, Sangster M, Sarawar S, Coleclough C, Doherty PC. Differential antigen burden modulates the gamma interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia. J Virol 1995;69:5592-5598.
29. Baumgarth N, Brown L, Jackson D, Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: Lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J Virol 1994;68:7575-7581.
30. Allan W, Tabi Z, Cleary A, Doherty PC. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol 1990;144:3980-3986.
31. + memory T cells. J Immunol 1995;154:5870-5875.
32. Hou S, Hyland L, Bradley LM, Watson SR, Doherty PC. Subverting lymph node trafficking by treatment with the Mel-14 monoclonal antibody to L-selectin does not prevent an effective host response to Sendai virus. J Immunol 1995;155:252-258.
33. Berg EL, et al. Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 1989;108:5-18.
34. Bradley LM, Watson SR, Swain SL. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J Exp Med 1994;180:2401-2406.
35. Tripp RA, Topham DJ, Watson SR, Doherty PC. Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol 1997;158:3716-3720.
36. Tabi Z, Lynch F, Ceredig R, Allan JE, Doherty PC. Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol 1988;113:268-277.
37. Yang HY, Dundon PL, Nahill SR, Welsh RM. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 1989;142:1710-1718.
38. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996;272:1947-1950.
39. Tripp RA, et al. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: Role for a viral superantigen? J Exp Med 1997;185:1641-1650.
40. Doherty PC, Tripp RA, Hamilton-Easton AM, Cardin RD, Woodland DL, Blackman MA. Tuning into immunological dissonance: An experimental model for infectious mononucleosis. Curr Opin Immunol 1997 (In press).
41. Doherty PC, Hamilton-Easton AM, Topham DJ, Riberdy J, Brooks JW, Cardin RD. Consequences of viral infections for lymphocyte compartmentalization and homeostasis. Semin Immunol 1997 (In press).
42. Yap KL, Ada GL, McKenzie IF. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978;273:238-239.
43. Lin YL, Askonas BA. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981;154:225-234.
44. Leung KN, Ada GL, McKenzie IF. Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med 1980;151:815-826.
45. Ada GL, Jones PD. The immune response to influenza infection. Curr Top Microbiol Immunol 1986;128: 1-54.
46. + T cells. Immunol Today 1990;11:55-59.
47. + lymphocyte subsets. Microb Pathog 1993;14:75-84.
48. Kelso A. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. J Immunol 1990;145:2167-2176.
49. + T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2. Int Immunol 1991;3:255-264.
50. Lukacher AE, Morrison LA, Braciale VL, Braciale TJ. T lymphocyte function in recovery from experimental viral infection: the influenza model. In: Steinman RM, North RJ, eds. Mechanisms of Host Resistance to Infectious Agents, Tumors and Allografts: A Conference in Recognition of the Trudeau Institute Centennial. New York: Rockefeller University Press; 1986. p. 233-254.
51. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994;180:1273-1282.
52. + cytolytic T cells. Nature 1990;344:742-746.
53. Koller BH, Smithies O. Altering genes in animals by gene targeting. Annu Rev Immunol 1992;10:705-730.
54. 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells. J Immunol 1994;152:2087-2097.
55. Baumgarth N, Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the focal cellular immune response in lung tissue. J Virol 1996;70:4411-4418.
56. Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med 1993;178:1725-1732.
57. Mo XY, Tripp RA, Sangster MY, Doherty PC. The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon. J Virol 1997;71:1906-1910.
58. 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol 1994;153:1246-1253.
59. 2-microglobulin-deficient mice. Science 1992;255:1576-1578.
60. + T cells from mice with Sendai virus pneumonia. J Virol 1993;67:6299-6302.
61. Tashiro M, Homma M. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2. J Virol 1985;53:228-234.
62. Horimoto T, Kawaoka Y. The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site. Virology 1995;210:466-470.
63. + T cells promote the clearance of influenza virus from major histocompatibility complex class II-/- respiratory epithelium. J Virol 1996;70:1288-1291.
64. + T cells in major histocompatibility complex class II-deficient mice. Science 1991;253:1417-1420.
65. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 1993;14:155-157.
66. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991;350:423-426.
67. + T Cells is inefficient in the absence of antibody. J Virol 1997 (Submitted).
68. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 1997;159:95-103.
69. Openshaw PJ. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol 1995;17: 187-201.
70. + T cells. Clin Exp Immunol 1992;88:527-536.
71. Openshaw P, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-1367.
72. Leung KN, Mak NK, Ada GL. The inductive requirements for the primary in vitro generation of delayed-type hypersensitivity response to influenza virus in mice. Immunology 1981;44:17-28.
73. Doherty PC, Gerhard W. Breakdown of the blood-cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus: Post-exposure treatment with monoclonal antibody promotes recovery. J Neuroimmunol 1981;1:227-237.
74. Palladino G, Mozdzanowska K, Washko G, Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995;69:2075-2081.
75. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979;27:51-177.
76. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997;15:405-431.
77. + T cells control a γ-herpesvirus infection via perform or Fas-based mechanisms. Nat Med 1997 (Submitted).
78. Guidotti LG, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994;91:3764-3768.
79. Guidotti LG, et al. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 1996;93:4589-4594.
80. Lukacher AE, Braciale VL, Bradale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-826.
81. Doherty PC, Ceredig R, Allan JE. Immunogenetic analysis of cellular interactions governing the recruitment of T lymphocytes and monocytes in lymphocytic choriomeningitis virus-induced immunopathology. Clin Immunol Immunopathol 1988;47: 19-26.
82. Doherty PC, Allan JE, Ceredig R. Contributions of host and donor T cells to the inflammatory process in murine lymphocytic choriomeningitis. Cell Immunol 1988;116:475-481.
83. + T cells requires direct targeting to virus-infected epithelium. Eur J Immunol 1995;25:111-116.
84. Kägi D, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995;25:3256-3262.
85. Usherwood EJ, et al. Immunological control of murine gammaherpesvirus infection is independent of perform. J Gen Virol 1997 (In press).
86. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
87. Mariani SM, Matiba B, Armandola EA, Krammer PH. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 1994;24:3119-3123.
88. Walsh CM, et al. Immune function in mice lacking the perform gene. Proc Natl Acad Sci USA 1994;91: 10854-10858.
89. Doherty PC, Zinkernagel RM. T-cell-mediated immunopathology in viral infections. Transplant Rev 1974;19:89-120.
90. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992;10:123-151.
91. Kelso A, Glasebrook AL. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones. J Immunol 1984;132:2924-2931.
92. b gene. J Immunol 1995;155:2955-2959.
93. Hou S, Mo XY, Hyland L, Doherty PC. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J Virol 1995;69:1429-1434.
94. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996;50:825-854.
95. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225-1230.
96. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 1989;58:5-8.
97. + cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-8063.
98. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-761.
99. Doherty PC. Virus infections in mice with targeted gene disruption. Curr Opin Immunol 1993;5:479-483.
100. Doherty PC, Tripp RA, Sixbey JW. Evasion of host immune responses by tumours and viruses. Ciba Found Symp 1994;187:245-256.
101. Doherty PC. Anatomical environment as a determinant in viral immunity. J Immunol 1995;155:1023-1027.